Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria)
| Time | Session |
|---|---|
|
11:05
11:10
|
|
|
11:10
11:50
|
|